Dexcom Inc (DXCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 505,000 | 568,900 | 500,900 | 451,800 | 405,100 |
| Cost of Goods | 161,100 | 169,800 | 160,500 | 167,700 | 148,600 |
| Gross Profit | 343,900 | 399,100 | 340,400 | 284,100 | 256,500 |
| Operating Expenses | 298,100 | 295,900 | 246,800 | 217,000 | 223,500 |
| Operating Income | 45,900 | 104,000 | 94,100 | 67,800 | 33,600 |
| Interest Expense | 4,700 | -42,400 | 24,400 | 20,300 | 15,400 |
| Other Income | 100 | 7,800 | 5,400 | -1,300 | 4,200 |
| Pre-tax Income | 41,300 | 154,200 | 75,100 | 46,200 | 22,400 |
| Income Tax | -15,200 | -257,100 | 2,900 | -100 | 2,500 |
| Net Income Continuous | 56,500 | 411,300 | 72,200 | 46,300 | 19,900 |
| Net Income | $56,500 | $411,300 | $72,200 | $46,300 | $19,900 |
| EPS Basic Total Ops | 0.15 | 1.10 | 0.19 | 0.12 | 0.06 |
| EPS Basic Continuous Ops | 0.15 | 1.09 | 0.19 | 0.12 | 0.05 |
| EPS Diluted Total Ops | 0.14 | 0.98 | 0.18 | 0.12 | 0.05 |
| EPS Diluted Continuous Ops | 0.14 | 0.95 | 0.18 | 0.12 | 0.05 |
| EBITDA(a) | $66,800 | $124,400 | $112,500 | $83,100 | $46,600 |